Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Despite these promising results, unanswered questions regarding the role and mechanisms of tirzepatide and other incretin-based therapy in the treatment of OSA remain
LiuZKangKShanSWangSLiXYongHet al
Briefings in Functional Genomics, 15 (6), 454-459
Brooks, [email protected] Specialty section: This article was submitted to Molecular and Structural Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
US$ 22.00
US$ 24.68
US$ 23.72
US$ 29.70
US$ 29.54
US$ 26.21
US$ 23.33
US$ 23.98
